Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05693649 · ClinicalTrials.gov registry record · NA
Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening
A NA study of Colorectal Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
- Active
- Registry status
- NA
- Development phase
- 20,000
- Enrollment target
- 1
- Study location
NCT05693649 is a NA study of Colorectal Cancer that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 20,000 participants, above the 1,457-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (1273% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05693649, a NA study of Colorectal Cancer, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 3-year pragmatic, randomized clinical trial among average-risk patients at diverse primary care practices who are overdue for colorectal (CRC) screening. This project aims to evaluate the effect of a centralized program that includes direct outreach to patients and visit-based, clinician directed nudges facilitated by the electronic health record (EHR) with follow-up text messaging on the uptake of CRC screening. The primary outcome is CRC screening completion at 3 years. Patient and clinician factors impacting the experience and effectiveness of the intervention will be explored through surveys and qualitative interviews.
Conditions Studied
Interventions
- BEHAVIORAL No Direct Patient Outreach
- BEHAVIORAL Direct Patient Outreach: Colonoscopy Only
- BEHAVIORAL Direct Patient Outreach: Sequential Choice
- BEHAVIORAL Visit-Based Nudge/Text
- BEHAVIORAL No Nudge/Text
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2023-06-07 |
| Est. Completion | 2026-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05693649
The ClinicalTrials.gov registry entry for NCT05693649 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,457-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (1273% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 5 interventions - of which No Direct Patient Outreach is the first listed.
NCT05693649 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05693649 about?
NCT05693649 is a clinical study titled "Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening". This is a 3-year pragmatic, randomized clinical trial among average-risk patients at diverse primary care practices who are overdue for colorectal (CRC) screening. This project aims to evaluate the effect of a centralized program that includes direct outreach to patients and visit-based, clinician d...
What is the current status of trial NCT05693649?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20,000 participants. The study started on 2023-06-07. Estimated completion is 2026-12-21.
What conditions does trial NCT05693649 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT05693649?
The interventions under investigation include: No Direct Patient Outreach (BEHAVIORAL), Direct Patient Outreach: Colonoscopy Only (BEHAVIORAL), Direct Patient Outreach: Sequential Choice (BEHAVIORAL), Visit-Based Nudge/Text (BEHAVIORAL), No Nudge/Text (BEHAVIORAL).
Who is sponsoring clinical trial NCT05693649?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05693649 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.